Atezolizumab Shows Promise in Rare Thyroid Cancer: Roche’s Immunotherapy Gains Ground in RET-Altered Tumors 1 year ago ByJohnIn Clinical TrialsLeadersResearch Updates
Duchenne Disappointment: Pfizer Halts Phase III Trial of Gene Therapy for DMD After Missed Endpoints 1 year ago ByJohnIn Breaking NewsClinical Trials
GLP-1 Agonists Show Cardiovascular Benefit Beyond Diabetes: Novo Nordisk’s Semaglutide Hits New Milestone 1 year ago ByJohnIn Breaking NewsInnovationPharma Industry UpdatesTop Stories
FDA Greenlights Psychedelic Therapy Trial for PTSD: COMPASS Pathways Moves Forward with Phase III Psilocybin Study 1 year ago ByJohnIn FDA ApprovalsResearch UpdatesTop Stories
Depemokimab Shows Promise in Severe Asthma: GSK’s IL-5 Inhibitor Hits Key Phase III Milestone 1 year ago ByJohnIn Pharma Industry UpdatesResearch UpdatesTop Stories
Prion Disease Breakthrough: Gene Silencing Strategy Shows Promise in Preclinical Models 1 year ago ByJohnIn Breaking NewsTop Stories
Skin Biopsy Breakthrough: New Diagnostic Tool for Parkinson’s and Synucleinopathies Shows High Accuracy 1 year ago ByJohnIn Breaking NewsBreakthroughsInnovationTop Stories
Alzheimer’s Setback: Roche’s Gantenerumab Fails to Meet Cognitive Endpoints in Phase III Trial 1 year ago ByJohnIn Biopharma HighlightsClinical TrialsResearch Updates
FDA Approves Teclistamab for Relapsed Multiple Myeloma Following Promising Trial Data 1 year ago ByJohnIn BreakthroughsFDA ApprovalsPharma Industry UpdatesTop Stories
Cassava Therapeutics Halts Alzheimer’s Program After Disappointing Trial Data 1 year ago ByJohnIn Breaking NewsClinical TrialsPharma Industry Updates
WHO Launches Global Initiative to Standardize Clinical Trial Data Sharing 1 year ago ByJohnIn Top Stories
Pharma Industry Faces Regulatory Shake-Up and Strategic Realignment Amid Market Pressures 1 year ago ByJohnIn Pharma Industry UpdatesResearch UpdatesTop Stories
NeuroVance Launches with $40M Series A to Tackle Treatment-Resistant Depression 1 year ago ByJohnIn Deals
Celosia Therapeutics Raises $16.75M to Advance Gene Therapy for ALS 1 year ago ByJohnIn BreakthroughsInvestmentsPartnerships
Dexcom and ŌURA Forge $75M Partnership to Advance Metabolic Health Monitoring 1 year ago ByJohnIn BreakthroughsPartnershipsPeopleTop Stories
